For use in men: For control of libido in severe hypersexuality and/or sexual deviation in the adult male. For reduction of drive in sexual deviations in men, cyproterone acetate 50 mg can be used when other interventions are considered inappropriate.
For the management of patients with prostatic cancer to suppress "flare" with initial LHRH analogue therapy, in long-term palliative treatment where LHRH analogues or surgery are contraindicated, not tolerated, or oral therapy is preferred, and in the treatment of hot flushes in patients under treatment with LHRH analogues or who have had an orchidectomy.
For use in women: Severe signs of androgenisation, e.g. very severe hirsutism, androgen-dependent severe loss of scalp hair eventually resulting in baldness (severe androgenic alopecia), often attended by severe forms of acne and/or seborrhoea.
Sign Out